Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D961H vs placebo to prevent peptic ulcers in low‑dose aspirin users
jRCT2080221059Phase 3
- Sponsor
- AstraZeneca
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gastric ulcer, duodenal ulcer and Peptic ulcer disease (PUD) comparing D961H 20 mg once daily with Placebo once daily (2 arms).
02
Drugs
esomeprazole
03
Conditions
gastric ulcerduodenal ulcerPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on jRCT2080221059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221059.